POISONS SCHEDULING. Monique Reyes Senior Pharmaceutical Officer Pharmaceutical Regulatory Unit NSW Ministry of Health

Similar documents
Drugs and Poisons Legislation Amendment (New Psychoactive and Other Substances) Act 2013 No 70

Act on Narcotic Drugs and Psychotropic Substances and Precursors thereof

Schedule Description Examples


Unofficial translation /Ministry of Social Affairs and Health. No. 548/2008. Government Decree on Narcotics Control

Medicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system

I am pleased to highlight for this Honourable House and the public. that today the Government will be laying amendments to the

New regulatory requirements DPCS Regulations 2017

Joy Wingfield LL M, MPhil, BPharm, FRPharmS, Dip Ag Vet Pharm, FCPP Honorary Professor of Pharmacy Law and Ethics, University of Nottingham, UK

Interstate dispensing : A case for uniform, intuitive legislation

Cancer Council New South Wales: Submission on Public Health (Tobacco) Regulations 2016

40 Use and Supply of Drugs or Medicines in Optometric Practice

MEDICAL COUNCIL OF NSW

Food Fortification Regulations, 2016 (Gazetted on 24 October, 2016) ARRANGEMENT OF SECTIONS PART I PRELIMINARY

Thailand s experience in developing the Reclassification guideline

Submission to the Misuse of Drugs Amendment Bill September Society and its Role and Functions. 29 September 2010

Amending Your Land Use Bylaw To Prepare For The Retail Sale Of Cannabis

January 19, Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9

Misuse of Drugs (Medicinal Cannabis) Amendment Bill

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis

Monash University Procedure. High Risk Scheduled Drugs and Poisons Procedure (S8/9/11)

LAW ON PREVENTION AND SUPPRESSION OF THE ABUSE OF NARCOTIC DRUGS

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

The Home Office Proposals to schedule pregabalin and gabapentin under the Misuse of Drugs Regulations 2001 January 2018

Medicines in Schedule 1 to the Medicine Regulations 1984 that reference the manufacturer s original pack

Update on the Legalization and Regulation of Cannabis. January 8, 2018 Regular Meeting of Delta Council

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis. February 2018

PIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES

Supplement No. 1 published with Extraordinary Gazette No. 65 dated 19 th August, 2016.

Review of Controlled Drugs and Substances Act

Guidance for Pharmacists on Extemporaneous Dispensing

European Legal Database on Drugs

Understanding the New Access to Cannabis for Medical Purposes Regulations

Guidance for Pharmacists on the Safe Supply of Non-Prescription Levonorgestrel 1500mcg for Emergency Hormonal Contraception

Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients

AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices

ALCOHOL & DRUG USE INCIDENT MANAGEMENT POLICY

STATUTORY INSTRUMENTS. S.I. No. 488 of 2008 REGULATION OF RETAIL PHARMACY BUSINESSES REGULATIONS 2008

Substance Misuse (Drugs, Alcohol and Tobacco) Policy

WAREHOUSING AND DISTRIBUTION OF CANNABIS PRODUCTS. RACI Pharmaceutical Science Group (NSW) Supply and Use of Medicinal Cannabis

WORK HEALTH & SAFETY NEWSLETTER November

How to change the legal classification of a medicine in New Zealand

Safe Prescribing and Dispensing of Controlled Drugs. Joint Guidance Medical Council and Pharmaceutical Society of Ireland

Date Marking. User Guide. Standard Date Marking of Food. December 2013

Coversheet: Medicinal cannabis: 100 day action

Name of the Substance

Drug and Alcohol Policy

Legalization of non-medical Cannabis OPSBA Update September 08, 2017

DRUG FREE WORKPLACE POLICY

LAO PEOPLE S DEMOCRATIC REPUBLIC PEACE INDEPENDENCE DEMOCRACY UNITY PROSPERITY

Sub. S.B. 119 As Passed by the Senate

Ontario s Narcotics Strategy

Recalling Resolution (59) 23 of 16 November 1959, on the extension of the activities of the Council of Europe in the social and cultural fields;

Alcohol, Tobacco and Other Drugs Minimum Standard. April 2015

Medicines and Cosmetics Regulation Unvalidated References:

Federation of Saint Kitts and Nevis

Workplace Drug and Alcohol Policy

REPUBLIC OF KENYA MINISTRY OF MEDICAL SERVICES PHARMACY AND POISONS BOARD

1.1 State the nature and purpose of a personal licence. 1.2 State the period of validity of a personal licence

PHARMACY AND POISONS BOARD OF HONG KONG

Appendix F Federation of State Medical Boards

Greens NSW Drug Regulation and Harm Minimisation Policy

REGULATION concerning Marketing Authorisations for Natural Medicinal Products and Registration of Traditional Herbal Medicinal Products, No. 142/2011.

Cannabis Legalization and Regulation in British Columbia Discussion Paper

The Role of the Responsible Pharmacist (RP)

Draft Guidance for Pharmacists on Extemporaneous Dispensing. Version 1

Cannabis Legalization

TOBACCO SMOKING (CONTROL) ACT

Unit title: Legal and Social Responsibilities of a Personal Licence Holder

The work of a poison control centre: What does it take?

PATIENT GROUP DIRECTION PROCEDURE

Guideline for the Rational Use of Controlled Drugs

MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH

Workplace Drug and Alcohol Policy

Schedules of Controlled Substances: Placement of Furanyl fentanyl, 4- Fluoroisobutyryl fentanyl, Acryl fentanyl, Tetrahydrofuranyl fentanyl, and

A combination of licensed medication and professional support is four times more likely to achieve a stop in smoking behaviour.

MICHIGAN MEDICAL MARIJUANA REGULATION: From Home Remedy to Criminalization. to State Regulated Industry. March 22, Stephen K.

California. Prescribing and Dispensing Profile. Research current through November 2015.

HACKNEY NEW SCHOOL DRUGS POLICY

Issue: March 2016 PROFESSIONAL STANDARDS AND GUIDANCE FOR ADVERTISING MEDICINES AND PROFESSIONAL SERVICES

Chapter 22. Uses and Limitations of Product Labeling for Public Safety

Criminal Justice (Psychoactive Substances) Bill Regulatory Impact Analysis

Re: Handling of gabapentin and pregabalin as Schedule 3 Controlled Drugs in health and justice commissioned services

GUILSBOROUGH ACADEMY DRUGS EDUCATION POLICY

Medicines in Schedule 1 to the Medicines Regulations 1984 that reference the manufacturer s original pack

Ringwood School Drug, Alcohol and Substance Misuse Policy

Patient Group Directions Policy

Health, Safety and Environment Management System. HSE-PRO-004 Drugs and Poisons Procedure

Appearance before House of Commons Standing Committee on Health as part of its Study on the Government s Role in Addressing Prescription Drug Abuse

2. The inclusion of public health focused restrictions around the sale and supply of these products.

Medical Devices. SOUTH AFRICA Bowman Gilfillan

Draft Guidelines on the Sale and Supply of Non- Prescription Medicinal Products from a Retail Pharmacy Business

Questions & answers on the use of cannabis sativa L. and cannabinoids (such as cannabidiol) as foodstuffs or within foodstuffs

Impact Summary: Therapeutic Products Bill Personal Import of Medicine by mail/courier

Prescribing drugs of dependence

Office of University Counsel and Secretary of the Board of Regents

NC General Statutes - Chapter 90 Article 5E 1

Date Marking User Guide Standard Date Marking of Packaged Food September 2010

Transcription:

POISONS SCHEDULING Monique Reyes Senior Pharmaceutical Officer Pharmaceutical Regulatory Unit NSW Ministry of Health

Topics Schedules of the Poisons Standard (Cth) Poisons and Therapeutic Goods Act 1966 (NSW) Drug Misuse and Trafficking Act 1985 (NSW) Licences & Authorities

Poisons Standard aka SUSMP (Standard for the Uniform Scheduling of Medicines and Poisons) Scheduling is a national classification system for controls on how medicines and chemicals are made available to the public, and other restrictions on their supply and use. Medicines and chemicals are classified into Schedules according to the level of regulatory control over the availability of the medicine or chemical, required to protect public health and safety.

Schedules Schedule 1 Schedule 2 Schedule 3 Schedule 4 Schedule 5 Schedule 6 Schedule 7 Schedule 8 Schedule 9 Schedule 10 Not currently in use Pharmacy Medicine Pharmacist Only Medicine Prescription Only Medicine OR Prescription Animal Remedy Caution Poison Dangerous Poison Controlled Drug Prohibited Substance Substances of such danger to health as to warrant prohibition of sale, supply and use

Restriction on access and availability Schedule 9 Schedule 10 Schedule 8 Schedule 4 Schedule 7 Schedule 3 Schedule 2 Schedule 6 Schedule 5 Prohibited Substance Substances of such danger to health as to warrant prohibition of sale, supply and use Controlled Drug Prescription Only Medicine OR Prescription Animal Remedy Dangerous Poison Pharmacist Only Medicine Pharmacy Medicine Poison Caution

Poisons Schedule 5: Caution Substances with a low potential for causing harm, the extent of which can be reduced through the use of appropriate packaging with simple warnings and safety directions on the label, such as "CAUTION - KEEP OUT OF REACH OF CHILDREN READ SAFETY DIRECTIONS BEFORE OPENING OR USING". Schedule 6: Poison Substances with a moderate potential for causing harm, the extent of which can be reduced through the use of distinctive packaging with strong warnings and safety directions on the label, such as "POISON - KEEP OUT OF REACH OF CHILDREN READ SAFETY DIRECTIONS BEFORE OPENING".

Poisons Schedule 7: Dangerous Poison Substances with a high potential for causing harm at low exposure and which require special precautions during manufacture, handling or use. These poisons should be available only to specialised or authorised users who have the skills necessary to handle them safely. Special regulations restricting their availability, possession, storage or use may apply. Schedule 10: Substances of such danger to health as to warrant prohibition of sale, supply and use - Substances which are prohibited for the purpose or purposes listed for each poison.

Medicines Schedule 2: Pharmacy Medicine Substances, the safe use of which may require advice from a pharmacist and which should be available from a pharmacy or, where a pharmacy service is not available, from a licensed person. Schedule 3: Pharmacist Only Medicine Substances, the safe use of which requires professional advice but which should be available to the public from a pharmacist without a prescription.

Medicines Schedule 4: Prescription Only Medicine, or Prescription Animal Remedy Substances, the use or supply of which should be by or on the order of persons permitted by State or Territory legislation to prescribe and should be available from a pharmacist on prescription. Schedule 8: Controlled Drug Substances which should be available for use but require restriction of manufacture, supply, distribution, possession and use to reduce abuse, misuse and physical or psychological dependence.

Medicines/Poisons Prohibited Substance Substances which may be abused or misused, the manufacture, possession, sale or use of which should be prohibited by law except when required for medical or scientific research, or for analytical, teaching or training purposes with approval of Commonwealth and/or State or Territory Health Authorities.

Derivatives of listed substances Schedule entry includes any concentration of all salts and derivatives of the poison unless it specifically states otherwise Similar in nature structurally, pharmacologically, and toxicologically Readily converted either physically or chemically to a scheduled poison There is no authority, other than the Courts, to determine the schedule of a substance that is not explicitly scheduled.

Exemptions to Scheduling Appendix A: general exemptions e.g. food, human blood products, radioisotopes for therapeutic use, in-vitro diagnostic analytical preparations (< 0.001% of an S1-S8) Appendix B: considered not to require control by scheduling e.g. ALCOHOL, DEHYDRATED Reason: Use pattern restricts hazard Area of use: Human therapeutic use Appendix G: dilute preparations - concentration cut-offs for specified poisons, where the Standard does not apply. Additionally, S1 to S6<10mg/L not scheduled

Advisory Committee on Scheduling Advisory Committee on Medicines Scheduling (ACMS) was established to advise and make recommendations to the Secretary of the Department of Health (or delegate) on the level of access required for medicines and in some instances chemicals Advisory Committee on Chemical Scheduling (ACCS) is the chemical counterpart Scheduling Policy Framework https://www.tga.gov.au/scheduling-medicines-poisons

Poisons and Therapeutic Goods Act 1966 NSW legislation Adopts Schedules 1 to 9 of the Poisons Standard, and interpretation provisions Regulates Schedule 10 Adopts packaging and labelling requirements of Standard Gives effect to Appendices A, B, F & K

NSW Licences and Authorities Licence to Supply by Wholesale of S2, S3, S4 and S8 Licence to Manufacture of S8 Authority to possess (but not supply) S8 for the purpose of analysis, research or instruction Authority to possess, use, manufacture or supply S9 for medical or scientific research, analytical, teaching or training purposes or for industrial or commercial purposes Authority to use, manufacture or supply S10

Drug Misuse and Trafficking Act 1985 Schedule 1 consists of substances in Schedule 4, Schedule 8, Schedule 9 of the SUSMP, and plants Provides for offences for possession, manufacture and supply of Schedule 1 DMTA and Schedule 9 of Standard Provides for offences for manufacture, supply and advertising of new psychoactive substances Provides for authority to possess, manufacture and supply Schedule 1 DMTA for the purpose of scientific research, instruction, analysis or study Relationship with Poisons and Therapeutic Goods Act

THE END Questions?